Graham Capital Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-48,749
| Closed | -$357K | – | 1487 |
|
|
2025
Q1 | $357K | Buy |
48,749
+11,172
| +30% | +$81.9K | 0.01% | 895 |
|
|
2024
Q4 | $321K | Buy |
+37,577
| New | +$321K | ﹤0.01% | 874 |
|
|
2023
Q4 | – | Sell |
-95,363
| Closed | -$299K | – | 1211 |
|
|
2023
Q3 | $299K | Buy |
+95,363
| New | +$299K | 0.01% | 710 |
|
|
2023
Q2 | – | Sell |
-77,661
| Closed | -$409K | – | 1197 |
|
|
2023
Q1 | $409K | Buy |
+77,661
| New | +$409K | 0.01% | 794 |
|
|
2022
Q4 | – | Sell |
-190,121
| Closed | -$789K | – | 1245 |
|
|
2022
Q3 | $789K | Buy |
+190,121
| New | +$789K | 0.03% | 577 |
|